Afuco™ Anti-IL5RA ADCC Therapeutic Antibody (Benralizumab), ADCC Enhanced
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to IL5RA. Benralizumab (INN) is a monoclonal antibody for the treatment of asthma. It is directed against the alpha-chain of the interleukin-5 receptor (CD125).
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-TAB-222 |
| Pricing | Inquiry |
| Host | Human |
| Target | IL5RA |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Applications | FC, IP, ELISA, Neut, FuncS |
| Storage | Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles. |